Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 4 |
NetGPI | no | yes: 0, no: 4 |
Related structures:
AlphaFold database: A4HJM5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 163 | 165 | PF00675 | 0.444 |
CLV_NRD_NRD_1 | 91 | 93 | PF00675 | 0.548 |
CLV_PCSK_KEX2_1 | 163 | 165 | PF00082 | 0.444 |
CLV_PCSK_KEX2_1 | 43 | 45 | PF00082 | 0.511 |
CLV_PCSK_KEX2_1 | 91 | 93 | PF00082 | 0.698 |
CLV_PCSK_PC1ET2_1 | 43 | 45 | PF00082 | 0.511 |
DEG_SPOP_SBC_1 | 122 | 126 | PF00917 | 0.647 |
DEG_SPOP_SBC_1 | 150 | 154 | PF00917 | 0.531 |
DOC_CYCLIN_yCln2_LP_2 | 75 | 81 | PF00134 | 0.654 |
DOC_MAPK_DCC_7 | 73 | 81 | PF00069 | 0.503 |
DOC_MAPK_gen_1 | 43 | 50 | PF00069 | 0.507 |
DOC_MAPK_MEF2A_6 | 43 | 50 | PF00069 | 0.601 |
DOC_USP7_MATH_1 | 113 | 117 | PF00917 | 0.619 |
DOC_USP7_MATH_1 | 122 | 126 | PF00917 | 0.749 |
DOC_USP7_MATH_1 | 150 | 154 | PF00917 | 0.719 |
DOC_USP7_MATH_1 | 19 | 23 | PF00917 | 0.564 |
DOC_USP7_MATH_1 | 49 | 53 | PF00917 | 0.675 |
DOC_WW_Pin1_4 | 133 | 138 | PF00397 | 0.597 |
DOC_WW_Pin1_4 | 67 | 72 | PF00397 | 0.614 |
LIG_14-3-3_CanoR_1 | 21 | 28 | PF00244 | 0.542 |
LIG_14-3-3_CanoR_1 | 67 | 71 | PF00244 | 0.646 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.698 |
LIG_FHA_1 | 100 | 106 | PF00498 | 0.518 |
LIG_FHA_1 | 122 | 128 | PF00498 | 0.596 |
LIG_LIR_Apic_2 | 65 | 71 | PF02991 | 0.538 |
LIG_PDZ_Class_2 | 195 | 200 | PF00595 | 0.572 |
LIG_Pex14_2 | 108 | 112 | PF04695 | 0.552 |
LIG_SH2_CRK | 68 | 72 | PF00017 | 0.507 |
LIG_SH2_NCK_1 | 68 | 72 | PF00017 | 0.507 |
LIG_SH2_STAT5 | 168 | 171 | PF00017 | 0.524 |
LIG_SH2_STAT5 | 68 | 71 | PF00017 | 0.512 |
LIG_SH3_2 | 39 | 44 | PF14604 | 0.506 |
LIG_SH3_3 | 33 | 39 | PF00018 | 0.682 |
LIG_WRC_WIRS_1 | 105 | 110 | PF05994 | 0.564 |
LIG_WW_3 | 70 | 74 | PF00397 | 0.644 |
MOD_CDC14_SPxK_1 | 70 | 73 | PF00782 | 0.642 |
MOD_CDK_SPxK_1 | 67 | 73 | PF00069 | 0.659 |
MOD_CK1_1 | 104 | 110 | PF00069 | 0.636 |
MOD_CK1_1 | 121 | 127 | PF00069 | 0.743 |
MOD_CK1_1 | 132 | 138 | PF00069 | 0.651 |
MOD_CK1_1 | 152 | 158 | PF00069 | 0.551 |
MOD_CK1_1 | 52 | 58 | PF00069 | 0.720 |
MOD_CK1_1 | 66 | 72 | PF00069 | 0.569 |
MOD_CK1_1 | 84 | 90 | PF00069 | 0.580 |
MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.773 |
MOD_GSK3_1 | 114 | 121 | PF00069 | 0.636 |
MOD_GSK3_1 | 129 | 136 | PF00069 | 0.625 |
MOD_GSK3_1 | 151 | 158 | PF00069 | 0.569 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.709 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.682 |
MOD_GSK3_1 | 62 | 69 | PF00069 | 0.628 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.529 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.727 |
MOD_NEK2_1 | 131 | 136 | PF00069 | 0.534 |
MOD_NEK2_1 | 63 | 68 | PF00069 | 0.599 |
MOD_NEK2_1 | 81 | 86 | PF00069 | 0.475 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.673 |
MOD_NEK2_2 | 49 | 54 | PF00069 | 0.610 |
MOD_PK_1 | 156 | 162 | PF00069 | 0.468 |
MOD_PKA_2 | 20 | 26 | PF00069 | 0.547 |
MOD_PKA_2 | 66 | 72 | PF00069 | 0.720 |
MOD_PKA_2 | 90 | 96 | PF00069 | 0.541 |
MOD_Plk_1 | 113 | 119 | PF00069 | 0.630 |
MOD_Plk_1 | 26 | 32 | PF00069 | 0.613 |
MOD_Plk_4 | 101 | 107 | PF00069 | 0.640 |
MOD_ProDKin_1 | 133 | 139 | PF00069 | 0.596 |
MOD_ProDKin_1 | 67 | 73 | PF00069 | 0.612 |
MOD_SUMO_rev_2 | 171 | 179 | PF00179 | 0.537 |
TRG_DiLeu_BaEn_1 | 101 | 106 | PF01217 | 0.641 |
TRG_ER_diArg_1 | 162 | 164 | PF00400 | 0.453 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S7X4V8 | Leishmania donovani | 64% | 99% |
A4I747 | Leishmania infantum | 63% | 99% |
E9B241 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 62% | 99% |